Cardiovascular Diseases
-
In the Lab Dr. Warnock has conducted research in the areas of cell and gene biomanufacturing, bioreactor design, tissue engineering and cellular mechanobiology. He is actively involved in engineering education research and has earned international acclaim for his work using problem-based learning to enable students to develop professional skills. He currently serves as the director…
-
In the Lab Kenan Song’s research, relevant to biomedical applications, leverages advanced manufacturing techniques like 3D printing to develop innovative solutions for the healthcare industry. Specifically, his work in creating microfluidic devices, porous Pelvic Organ Prolapse scaffolds, and artificial artery vessels caters to critical needs in cardiovascular and regenerative medicine. Through 3D printing, he can…
-
In the Lab Reproductive challenges in both human and livestock populations are of significant concern and are often a direct result of abnormal germ cell (oocyte and sperm) development. Aberrant germ cell development significantly affects human fertility, is the leading cause of early pregnancy loss and results in birth defects such as Down’s syndrome and…
-
In the Lab Dr. Zion T.H. Tse is an Adjunct Associate Professor in the Faculty of Engineering. Formerly, he was a researcher at Harvard Medical School and Brigham and Women’s. His academic and professional experience has related to electronics instrumentation, medical devices and surgical robotics. Dr. Tse has designed and prototyped a broad range of…
-
In the Lab According to the CDC, chronic diseases such as cardiovascular disease and cancer account for seven of the 10 leading causes of death in the U.S. Advanced age is a common and significant risk factor for chronic diseases, and as the population rapidly ages in the coming decades, the prevalence of those diseases…
-
In the Lab Interleukin-1 beta (IL-1ß) is a cytokine that is produced by the immune system and a variety of cells in response to an insult. Previous work in our lab has demonstrated that this cytokine is capable of affecting specific neurotransmitter systems in specific parts of the brain by crossing the blood brain barrier…
-
Bio Dr. P. S. MohanKumar was born in Tamil Nadu, India. He received his veterinary degree from the Madras Veterinary College, Chennai, India. He went onto pursue a PhD degree in neuroendocrinology at Kansas State University following it with a stint of postdoctoral fellowship at University of Kansas Medical Center. After a brief period as…
-
In the Lab Functional heterogeneity is a significant barrier to the clinical translation of many cellular therapies, including mesenchymal stromal cells (MSCs). Though MSCs have shown promise in treatment of immune diseases, the mechanisms of action and critical quality attributes (CQAs, predictors of function) in different therapeutic settings are largely unknown. The overall goal of the…
-
In the Lab Blood/material interaction is critical to the success of implantable medical devices, ranging from simple catheters, stents and grafts, to complex extracorporeal artificial organs which are used in thousands of patients every day. There are two major limiting factors to clinical application of blood contacting materials: 1) platelet activation leading to thrombosis, and…